 |
|
Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease
Nam-Jun Cho, Chi-Young Choi, Samel Park, Sang-Ho Park, Eun Young Lee, Hyo-Wook Gil
Kidney Res Clin Pract. 2018;37(1):59-68. Published online 2018 Mar 31 DOI: https://doi.org/10.23876/j.krcp.2018.37.1.59
|
|
Citations to this article as recorded by
 Research Progress on the Potential Mechanisms of Acute Kidney Injury and Chronic Kidney Disease Induced by Proton Pump Inhibitors
Zhiyong Song, Xuezhong Gong
Integrative Medicine in Nephrology and Andrology.2023;[Epub] CrossRef Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
Andrêza Soares dos Santos, Sara Teles de Menezes, Isabella Ribeiro Silva, William Neves Oliveira, Mariana Linhares Pereira, José Geraldo Mill, Sandhi Maria Barreto, Roberta Carvalho Figueiredo
BMC Nephrology.2023;[Epub] CrossRef Nephrotoxins and acute kidney injury – The consensus of the Taiwan acute kidney injury Task Force
Wei-Chun Huang, Mei-Tzu Wang, Tai-Shuan Lai, Kuo-Hua Lee, Shih-Chieh Shao, Chien-Hao Chen, Chien-Hao Su, Yih-Ting Chen, Junne-Ming Sung, Yung-Chang Chen
Journal of the Formosan Medical Association.2022; 121(5): 886. CrossRef Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, Sung Yong Moon, So Young Kim, Hyun Yong Koh, Jee Myung Yang, Su Jin Jeong, Sun Joon Moon, Joo Young Cho, In Kyung Yoo, Dong Keon Yon
Gut.2021; 70(1): 76. CrossRef Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD‐REIN cohort study
Sophie Liabeuf, Oriane Lambert, Marie Metzger, Aghiles Hamroun, Maurice Laville, Solène M. Laville, Luc Frimat, Roberto Pecoits‐Filho, Denis Fouque, Ziad A. Massy, Christian Jacquelinet, Bénédicte Stengel
British Journal of Clinical Pharmacology.2021; 87(7): 2967. CrossRef Vascular Calcification as a Novel Risk Factor for Kidney Function Deterioration in the Nonelderly
Samel Park, Nam‐Jun Cho, Nam Hun Heo, Eun‐Jung Rhee, Hyowook Gil, Eun Young Lee
Journal of the American Heart Association.2021;[Epub] CrossRef Proton Pump Inhibitor-Induced Galactorrhea in a Kidney Transplant Recipient: A Friend or Foe?
Marios Prikis, Julie MacDougall, Nina Narasimhadevara
Case Reports in Transplantation.2020; 2020: 1. CrossRef Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review
Ejaz Cheema
Journal of Pharmaceutical Policy and Practice.2019;[Epub] CrossRef Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients
Hsun Yang, Shiun-Yang Juang, Kuan-Fu Liao
Diabetes Research and Clinical Practice.2019; 147: 67. CrossRef Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients
Hee Jeong Lee, Haekyung Lee, Song Hee Oh, Joonbyung Park, Suyeon Park, Jin Seok Jeon, HyunJin Noh, Dong Cheol Han, Soon Hyo Kwon, Abelardo I. Aguilera
PLOS ONE.2018; 13(9): e0203878. CrossRef
|